Free Trial

Voyager Therapeutics (VYGR) Short Interest Ratio & Short Volume

Voyager Therapeutics logo
$3.49 -0.06 (-1.69%)
Closing price 07/11/2025 04:00 PM Eastern
Extended Trading
$3.65 +0.16 (+4.58%)
As of 07/11/2025 07:26 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Voyager Therapeutics Short Interest Data

Voyager Therapeutics (VYGR) has a short interest of 9.39 million shares, representing 18.13% of the float (the number of shares available for trading by the public). This marks a 139.54% increase in short interest from the previous month. The short interest ratio (days to cover) is 2.0, indicating that it would take 2.0 days of the average trading volume of 487,782 shares to cover all short positions.

Current Short Interest
9,390,000 shares
Previous Short Interest
3,920,000 shares
Change Vs. Previous Month
+139.54%
Dollar Volume Sold Short
$29.20 million
Short Interest Ratio
2.0 Days to Cover
Last Record Date
June 30, 2025
Outstanding Shares
55,340,000 shares
Short Percent of Float
18.13%
Today's Trading Volume
829,728 shares
Average Trading Volume
487,782 shares
Today's Volume Vs. Average
170%
Short Selling Voyager Therapeutics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Voyager Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

VYGR Short Interest Over Time

VYGR Days to Cover Over Time

VYGR Percentage of Float Shorted Over Time

Voyager Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
6/30/20259,390,000 shares $29.20 million +139.5%18.1%2 $3.11
6/15/20253,920,000 shares $12.94 million +22.5%7.6%7.5 $3.30
5/31/20253,200,000 shares $8.70 million +13.9%6.1%6.7 $2.72
5/15/20252,810,000 shares $9.22 million -3.1%5.4%7.9 $3.28
4/30/20252,900,000 shares $10.32 million -3.3%N/A7.8 $3.56
4/15/20253,000,000 shares $9.63 million +2.4%5.8%8.1 $3.21
3/31/20252,930,000 shares $9.90 million +4.3%5.6%7.6 $3.38
3/15/20252,810,000 shares $10.96 million +4.1%5.4%7.6 $3.90
2/28/20252,700,000 shares $11.02 million -0.7%5.2%7.3 $4.08
2/15/20252,720,000 shares $11.51 million +4.2%5.2%6.8 $4.23
1/31/20252,610,000 shares $14.22 million +2.4%N/A5.9 $5.45
1/15/20252,550,000 shares $13.23 million +3.7%N/A5 $5.19
12/31/20242,460,000 shares $13.95 million -2.8%N/A4.5 $5.67
12/15/20242,530,000 shares $15.86 million -1.2%N/A4.4 $6.27
11/30/20242,560,000 shares $17.56 million +4.9%N/A4.3 $6.86
11/15/20242,440,000 shares $13.76 million -17.3%N/A4.3 $5.64
10/31/20242,950,000 shares $20.15 million -14.5%N/A5.4 $6.83
10/15/20243,450,000 shares $23.63 million +15.4%N/A6.8 $6.85
9/30/20242,990,000 shares $17.49 million -29.7%N/A6.6 $5.85
9/15/20244,250,000 shares $26.56 million +5.5%N/A9.4 $6.25
8/31/20244,030,000 shares $26.44 million -3.6%N/A9.4 $6.56
8/15/20244,180,000 shares $27.13 million +5.8%N/A9.7 $6.49
7/31/20243,950,000 shares $36.30 million -2.7%N/A9.1 $9.19
7/15/20244,060,000 shares $36.38 million +5.7%N/A9.1 $8.96
6/30/20243,840,000 shares $30.37 million -3.2%N/A8.2 $7.91
6/15/20243,968,500 shares $33.77 million -6.8%N/A8.1 $8.51
5/31/20244,260,000 shares $35.78 million -1.8%N/A7.3 $8.40
5/15/20244,340,000 shares $37.19 million +3.1%N/A6.4 $8.57
4/30/20244,210,000 shares $32.92 million +21.7%N/A6.4 $7.82
4/15/20243,460,000 shares $28.51 million +3.9%N/A5.5 $8.24
3/31/20243,330,000 shares $31.00 million +44.2%N/A4.4 $9.31
3/15/20242,310,000 shares $21.44 million +2.2%N/A2.5 $9.28
2/29/20242,260,000 shares $18.80 million +5.1%N/A2.9 $8.32
2/15/20242,150,000 shares $16.53 million +9.1%5.9%3.1 $7.69
1/31/20241,970,000 shares $14.32 million +8.8%5.4%3 $7.27
1/15/20241,810,000 shares $14.23 million +4.0%5.0%2.9 $7.86
12/31/20231,740,000 shares $14.69 million +1.8%N/A3.1 $8.44
12/15/20231,710,000 shares $13.65 million +3.0%4.9%8.5 $7.98
11/30/20231,660,000 shares $12.05 million -13.5%4.8%7.4 $7.26
11/15/20231,920,000 shares $12.92 million -4.5%5.5%8.3 $6.73
AI Meltdown Imminent: Dump These Stocks Now! (Ad)

If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new invention… This could send many popular AI stocks crashing, including Nvidia. And it could happen starting as soon as June 1st.

Click here to see the details and learn how to prepare for the next AI revolution
10/31/20232,010,000 shares $13.21 million -1.0%5.8%8.3 $6.57
10/15/20232,030,000 shares $15.00 million +1.0%5.9%7.7 $7.39
9/30/20232,010,000 shares $15.58 million +0.5%5.8%6.8 $7.75
9/15/20232,000,000 shares $15.92 million -3.9%5.7%6.1 $7.96
8/31/20232,080,000 shares $20.84 million +2.5%6.0%4.6 $10.02
8/15/20232,030,000 shares $19.29 million +4.1%5.8%3.8 $9.50
7/31/20231,950,000 shares $18.17 million -4.9%5.6%3 $9.32
7/15/20232,050,000 shares $19.50 million -2.4%6.0%3.1 $9.51
6/30/20232,100,000 shares $24.05 million +57.9%6.1%3.3 $11.45
6/15/20231,330,000 shares $17.52 million +10.8%3.9%2.2 $13.17
5/31/20231,200,000 shares $13.67 million +9.1%3.5%2.5 $11.39
5/15/20231,100,000 shares $11.44 million +7.8%3.2%2.5 $10.40
4/30/20231,020,000 shares $7.40 million No Change3.5%3 $7.25
4/15/20231,020,000 shares $8.23 million No Change3.5%3.5 $8.07
3/31/20231,020,000 shares $7.86 million No Change3.7%2.5 $7.71
3/15/20231,020,000 shares $8.18 million +23.0%3.7%2.6 $8.02
2/28/2023829,200 shares $5.95 million -1.7%3.3%2.3 $7.18
2/15/2023843,900 shares $6.40 million -1.9%3.4%2.7 $7.58
1/31/2023860,400 shares $8.12 million -21.8%3.1%2.9 $9.44
1/15/20231,100,000 shares $11.86 million +11.8%4.0%4.2 $10.78
12/30/2022983,600 shares $6.00 million +13.0%3.6%4.6 $6.10
12/15/2022870,200 shares $5.05 million +0.6%3.2%7 $5.80
11/30/2022865,100 shares $5.14 million -4.2%3.2%6.8 $5.94
11/15/2022902,700 shares $4.99 million -2.5%3.3%5.8 $5.53
10/31/2022926,200 shares $4.80 million +31.9%3.4%5 $5.18
10/15/2022702,300 shares $4.03 million -29.3%2.6%3.6 $5.74
9/30/2022993,400 shares $5.88 million -19.2%3.6%5 $5.92
9/15/20221,230,000 shares $8.25 million +12.8%4.5%5.9 $6.71
8/31/20221,090,000 shares $6.51 million +5.8%4.0%4.5 $5.97
8/15/20221,030,000 shares $6.20 million -13.5%3.8%4.1 $6.02
7/31/20221,190,000 shares $7.97 million +51.1%4.5%4.2 $6.70
7/15/2022787,600 shares $5.40 million -16.3%3.0%2.4 $6.86
6/30/2022941,300 shares $5.56 million -0.2%3.6%1.8 $5.91
6/15/2022943,200 shares $4.65 million -24.5%3.6%1.6 $4.93
5/31/20221,250,000 shares $7.58 million -1.6%4.8%1.6 $6.06
5/15/20221,270,000 shares $8.19 million -2.3%4.9%1.5 $6.45
4/30/20221,300,000 shares $9.53 million +4.8%5.0%1.6 $7.33
4/15/20221,240,000 shares $11.06 million +28.9%4.8%1.5 $8.92
3/31/2022962,300 shares $7.33 million -30.3%3.8%1.5 $7.62
3/15/20221,380,000 shares $9.04 million -6.1%5.4%2.3 $6.55
2/28/20221,470,000 shares $5.84 million -19.2%5.7%3.1 $3.97
2/15/20221,820,000 shares $6.68 million +9.6%7.1%4.7 $3.67
1/31/20221,660,000 shares $4.75 million +49.6%6.5%3.6 $2.86
1/15/20221,110,000 shares $3.26 million -1.8%4.3%2 $2.94
12/31/20211,130,000 shares $3.06 million No Change4.4%0.9 $2.71
12/15/20211,130,000 shares $3.30 million -7.4%4.4%0.2 $2.92
11/30/20211,220,000 shares $3.71 million -29.5%4.7%0.2 $3.04
11/15/20211,730,000 shares $5.92 million -27.9%6.7%0.3 $3.42
10/29/20212,400,000 shares $8.69 million -24.5%9.3%0.4 $3.62
10/15/20213,180,000 shares $13.04 million +304.4%12.3%0.6 $4.10
AI Meltdown Imminent: Dump These Stocks Now! (Ad)

If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new invention… This could send many popular AI stocks crashing, including Nvidia. And it could happen starting as soon as June 1st.

Click here to see the details and learn how to prepare for the next AI revolution
9/30/2021786,400 shares $2.07 million -9.5%3.0%0.2 $2.63
9/15/2021868,700 shares $2.61 million -4.7%3.4%2.7 $3.01
8/31/2021911,400 shares $2.97 million -2.6%3.5%2.6 $3.26
8/13/2021936,100 shares $2.77 million -4.7%3.6%2.3 $2.96
7/30/2021982,200 shares $3.09 million +10.7%3.8%2.2 $3.15
7/15/2021887,600 shares $3.08 million +1.5%3.4%1.5 $3.47
6/30/2021874,300 shares $3.61 million -57.8%3.4%1.4 $4.13
6/15/20212,070,000 shares $9.73 million -11.2%8.0%3.7 $4.70
5/28/20212,330,000 shares $9.93 million +2.2%9.0%4.1 $4.26
5/14/20212,280,000 shares $9.78 million -11.6%8.8%3.8 $4.29
4/30/20212,580,000 shares $12.69 million +16.2%10.4%4.1 $4.92
4/15/20212,220,000 shares $10.63 million +1.4%9.0%3.6 $4.79
3/31/20212,190,000 shares $10.51 million +9.5%8.9%4.3 $4.80
3/15/20212,000,000 shares $11.46 million +0.5%8.1%3.6 $5.73
2/26/20211,990,000 shares $12.40 million +5.3%8.0%3.8 $6.23
2/12/20211,890,000 shares $13.80 million -1.1%7.6%4 $7.30
1/29/20211,910,000 shares $14.69 million +20.9%7.8%4.3 $7.69
1/15/20211,580,000 shares $14.09 million -6.5%6.5%4 $8.92
12/31/20201,690,000 shares $12.30 million +10.5%6.9%4.7 $7.28
12/15/20201,530,000 shares $12.87 million +10.1%N/A0 $8.41
11/30/20201,390,000 shares $11.76 million +7.8%5.7%5.1 $8.46
10/30/20201,210,000 shares $13.26 million -3.2%5.0%5.6 $10.96
10/15/20201,250,000 shares $15.21 million +6.8%5.1%5.6 $12.17
9/30/20201,170,000 shares $12.48 million -45.8%4.8%4.6 $10.67
9/15/20202,160,000 shares $23.44 million +0.5%8.9%8 $10.85
8/31/20202,150,000 shares $25.35 million -3.2%8.8%7.9 $11.79
8/14/20202,220,000 shares $25.06 million -2.2%9.2%7.5 $11.29
7/31/20202,270,000 shares $25.13 million -18.4%9.5%7.2 $11.07
7/15/20202,780,000 shares $35.64 million -11.5%11.6%8.6 $12.82

VYGR Short Interest - Frequently Asked Questions

What is Voyager Therapeutics' current short interest?

Short interest is the volume of Voyager Therapeutics shares that have been sold short but have not yet been covered or closed out. As of June 30th, investors have sold 9,390,000 shares of VYGR short. 18.13% of Voyager Therapeutics' shares are currently sold short. Learn More on Voyager Therapeutics' current short interest.

What is a good short interest ratio for Voyager Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. VYGR shares currently have a short interest ratio of 2.0. Learn More on Voyager Therapeutics's short interest ratio.

What is a good short interest percentage for Voyager Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 18.13% of Voyager Therapeutics' floating shares are currently sold short.

Is Voyager Therapeutics' short interest increasing or decreasing?

Voyager Therapeutics saw a increase in short interest in the month of June. As of June 30th, there was short interest totaling 9,390,000 shares, an increase of 139.5% from the previous total of 3,920,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Voyager Therapeutics' short interest compare to its competitors?

18.13% of Voyager Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Voyager Therapeutics: Immatics N.V. (3.46%), Day One Biopharmaceuticals, Inc. (15.66%), Ginkgo Bioworks Holdings, Inc. (31.50%), Maravai LifeSciences Holdings, Inc. (13.29%), Stoke Therapeutics, Inc. (23.34%), Urogen Pharma (42.26%), MeiraGTx Holdings PLC (5.02%), Zevra Therapeutics, Inc. (3.69%), ChromaDex Co. (4.29%), Relay Therapeutics, Inc. (13.19%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($72.10 billion), Invesco QQQ ($26.89 billion), iShares Russell 2000 ETF ($19.61 billion), MicroStrategy Incorporated ($9.52 billion), iShares 20+ Year Treasury Bond ETF ($8.70 billion), WD-40 Company ($7.66 billion), Technology Select Sector SPDR Fund ($6.10 billion), Invesco S&P 500 Equal Weight ETF ($5.80 billion), Invesco S&P 500 Top 50 ETF ($5.53 billion), and Vanguard Large-Cap ETF ($5.35 billion). View all of the most shorted stocks.

What does it mean to sell short Voyager Therapeutics stock?

Short selling VYGR is an investing strategy that aims to generate trading profit from Voyager Therapeutics as its price is falling. VYGR shares are trading down $0.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Voyager Therapeutics?

A short squeeze for Voyager Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of VYGR, which in turn drives the price of the stock up even further.

How often is Voyager Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VYGR, twice per month. The most recent reporting period available is June, 30 2025.




This page (NASDAQ:VYGR) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners